# Safety and Effectiveness of the Alma System in Treating Primary Postpartum Hemorrhage

> **NCT06166771** · NA · UNKNOWN · sponsor: **ResQ Medical Ltd** · enrollment: 10 (estimated)

## Conditions studied

- Postpartum Hemorrhage \(PPH\)
- Postpartum Hemorrhage \(Primary\)
- PPH

## Interventions

- **DEVICE:** Alma system

## Key facts

- **NCT ID:** NCT06166771
- **Lead sponsor:** ResQ Medical Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-09-09
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06166771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06166771, "Safety and Effectiveness of the Alma System in Treating Primary Postpartum Hemorrhage". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06166771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*